What Does the Sale of Rapport Therapeutics Stock Worth Over $400,000 by the Chief Operating Officer Mean for Investors?
This clinical-stage biotech focused on CNS disorders reported a notable insider sale amid a year of exceptional stock appreciation.
Read the full articleYou might also wanna read
CEOs Sell Millions Worth of These 3 Big Name Stocks—What It Means for Investors
CEOs at Casey's, Rocket Lab and RH sold millions in shares recently, but context suggests the moves reflect diversification rather than clea
Biotech NRx to sell new shares to fund growth and operations
#NRXP NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
Insider Sell: Sukumar Nagendran Sells 200,000 Shares of Taysha Gene Therapies Inc (TSHA)
Related Stocks: TSHA
Is SpaceX stock worth $135 a share? Pros weigh in on IPO
Elon Musk wants to sell you the world’s biggest IPO — and one of the most expensive. SpaceX insiders will reap a huge return, but what about
nbcnews.to·1mo agoGlaxoSmithKline announces sale of shares in Quest Diagnostics Inc.
GSK announces it's sold 5,749,157 shares of common stock, par value of $0.01 per share of Quest Diagnostics Inc.
Cue Biopharma to sell 1.418M shares at $33.21 in private placement
See the rest of the story here . thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The F
Comments
Sign in to join the conversation.
No comments yet. Be the first.